Evidence map›Paper›PMID 31389140›Full record

ArticleAging cell2019

Single xenotransplant of rat brown adipose tissue prolonged the ovarian lifespan of aging mice by improving follicle survival.

Liang-Jian Chen, Zhi-Xia Yang, Yang Wang, Lei Du, Yan-Ru Li, Na-Na Zhang, Wen-Yi Gao, Rui-Rui Peng, Feng-Yu Zhu, Li-Li Wang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Aging cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Editorial: Aging and the oocyte.Frontiers in endocrinology · 2024
    Article
  8. Article
  9. Brown Adipose Tissue Transplantation.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Liang-Jian ChenState Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Zhi-Xia YangState Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Yang WangState Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Lei DuState Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Yan-Ru LiState Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Na-Na ZhangState Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Wen-Yi GaoState Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Rui-Rui PengState Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Feng-Yu ZhuState Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Li-Li WangState Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Cong-Rong LiState Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China.
Jian-Min LiAnimal Core Facility, Nanjing Medical University, Nanjing, China.
Fu-Qiang WangAnalysis & Test Center, Nanjing Medical University, Nanjing, China.
Qing-Yuan SunState Key Lab of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Dong ZhangState Key Lab of Reproductive Medicine, Nanjing Medical University, Nanjing, China.ORCID 0000-0002-0257-4441
Nanjing Medical University · CNCentral South University · CNChinese Academy of Sciences · CN

Funding

General Program of the National Natural Science Foundation of China 31671561National Key Research and Development Program of China 2018YFC1003400National Natural Science Foundation of China 31871504
6 · The paper itself

Abstract

Prolonging the ovarian lifespan is attractive and challenging. An optimal clinical strategy must be safe, long-acting, simple, and economical. Allotransplantation of brown adipose tissue (BAT), which is most abundant and robust in infants, has been utilized to treat various mouse models of human disease. Could we use BAT to prolong the ovarian lifespan of aging mice? Could we try BAT xenotransplantation to alleviate the clinical need for allogeneic BAT due to the lack of voluntary infant donors? In the current study, we found that a single rat-to-mouse (RTM) BAT xenotransplantation did not cause systemic immune rejection but did significantly increase the fertility of mice and was effective for more than 5 months (equivalent to 10 years in humans). Next, we did a series of analysis including follicle counting; AMH level; estrous cycle; mTOR activity; GDF9, BMP15, LHR, Sirt1, and Cyp19a level; ROS and annexin V level; IL6 and adiponectin level; biochemical blood indices; body temperature; transcriptome; and DNA methylation studies. From these, we proposed that rat BAT xenotransplantation rescued multiple indices indicative of follicle and oocyte quality; rat BAT also improved the metabolism and general health of the aging mice; and transcriptional and epigenetic (DNA methylation) improvement in F0 mice could benefit F1 mice; and multiple KEGG pathways and GO classified biological processes the differentially expressed genes (DEGs) or differentially methylated regions (DMRs) involved were identical between F0 and F1. This study could be a helpful reference for clinical BAT xenotransplantation from close human relatives to the woman.

Indexed as

Cellular SenescenceLongevityAdipose Tissue, BrownAnimalsFemaleMiceOvarian FollicleOvaryRatsRats, Sprague-DawleyTransplantation, Heterologousagingbrown adipose tissue (BAT)lifespanmiceovaryratxenotransplant

Identifiers

PMID31389140
PMCPMC6826128
OpenAlexW2964969019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.